Market Place
Sourcing Support
All News #Library
Biotech
Viatris settles lawsuit over use of woman`s `immortal` cells
13 Mar 2026 //
REUTERS
FDA Accepts Viatris Supplemental New Drug Application for MR-141
25 Feb 2026 //
PR NEWSWIRE
Biocon Biologics Gets Credit Boost From S&P, Outlook Stable
30 Jan 2026 //
INDPHARMAPOST
Biocon To Merge Biocon Biologics In $5.5 Billion Deal
06 Dec 2025 //
REUTERS
Locus Bio In Research Collab For Precision Antibacterial Therapy
28 Oct 2025 //
BUSINESSWIRE
Viatris Reports Positive Ph 3 MR-141 Results in Eye Care
26 Jun 2025 //
PR NEWSWIRE
Biocon Biologics Completes Integration of Viatris™ Biosimilar Business
30 Nov 2023 //
GLOBENEWSWIRE
FTC takes patent scrutiny to Sanofi, Mylan`s insulin case
22 Nov 2023 //
FIERCE PHARMA
Viatris gets US agency to review Novo semaglutide patent
05 Oct 2023 //
FIERCE PHARMA
On track to integrate major part Viatris``acquired biosimilars biz this fiscal
30 Aug 2023 //
ECONOMICTIMES
Biocon Biologics takes over Viatris` biosimilar biz in over 70 countries
05 Jul 2023 //
ECONOMIC TIMES
Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results
27 Feb 2023 //
PR NEWSWIRE
Biocon Biologics has comprehensive plan to integrate Viatris business
16 Feb 2023 //
ECONOMIC TIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.